Gene · 6135
Papers1,885
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,885
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Apoptosis and NETotic cell death affect diabetic nephropathy independently: An study integrative study encompassing bioinformatics, machine learning, and experimental validation. | Genomics | 2024 | 38851464 | PubTator, text mining | PubMed |
| Oncogenic role of RNA-binding protein GNL2 in glioma: Promotion of tumor development through enhancing protein synthesis. | Oncol Lett | 2024 | 38779136 | PubTator, text mining | PubMed |
| Role of ribosomal pathways and comorbidity in COVID-19: Insight from SARS-CoV-2 proteins and host proteins interaction network analysis. | Heliyon | 2024 | 38694063 | PubTator, text mining | PubMed |
| [A child with persistent anaemia]. | Tidsskr Nor Laegeforen | 2024 | 38506013 | PubTator, text mining | PubMed |
| Recapitulating and reversing human brain ribosomopathy defects via the maladaptive integrated stress response. | Sci Adv | 2024 | 38306425 | PubTator, text mining | PubMed |
| Research progress of N1-methyladenosine RNA modification in cancer. | Cell Commun Signal | 2024 | 38291517 | PubTator, text mining | PubMed |
| Deficiency of the ribosomal protein uS10 (RPS20) reorganizes human cells translatome according to the abundance, CDS length and GC content of mRNAs. | Open Biol | 2024 | 38290548 | PubTator, text mining | PubMed |
| The DNA damage sensor ATM kinase interacts with the p53 mRNA and guides the DNA damage response pathway. | Mol Cancer | 2024 | 38263180 | PubTator, text mining | PubMed |
| Ribosomal protein L24 mediates mammalian microRNA processing in an evolutionarily conserved manner. | Cell Mol Life Sci | 2024 | 38261097 | PubTator, text mining | PubMed |
| Inferring Drug Set and Identifying the Mechanism of Drugs for PC3. | Int J Mol Sci | 2024 | 38255837 | PubTator, text mining | PubMed |
| Decoding Ribosome Heterogeneity: A New Horizon in Cancer Therapy. | Biomedicines | 2024 | 38255260 | PubTator, text mining | PubMed |
| Deciphering the role of neddylation in tumor microenvironment modulation: common outcome of multiple signaling pathways. | Biomark Res | 2024 | 38191508 | PubTator, text mining | PubMed |
| Directional Endothelial Communication by Polarized Extracellular Vesicle Release. | Circ Res | 2024 | 38174557 | PubTator, text mining | PubMed |
| Inhibition of TAF1B impairs ribosome biosynthesis and suppresses cell proliferation in stomach adenocarcinoma through promoting c-MYC mRNA degradation. | Heliyon | 2024 | 38169774 | PubTator, text mining | PubMed |
| Quantitative Proteomics of Tissue-Infiltrating T Cells From CRC Patients Identified Lipocalin-2 Induces T-Cell Apoptosis and Promotes Tumor Cell Proliferation by Iron Efflux. | Mol Cell Proteomics | 2024 | 38072118 | PubTator, text mining | PubMed |
| Effects of the Nonstructural Protein-Nucleolar and Coiled-Body Phosphoprotein 1 Protein Interaction on rRNA Synthesis Through Telomeric Repeat-Binding Factor 2 Regulation Under Nucleolar Stress. | AIDS Res Hum Retroviruses | 2024 | 38062753 | PubTator, text mining | PubMed |
| Pan-cancer analysis of 60S Ribosomal Protein L7-Like 1 (RPL7L1) and validation in liver hepatocellular carcinoma. | Transl Oncol | 2024 | 38042135 | PubTator, text mining | PubMed |
| RPF2 mediates the CARM1‑MYCN axis to promote chemotherapy resistance in colorectal cancer cells. | Oncol Rep | 2024 | 37997821 | PubTator, text mining | PubMed |
| Diamond-Blackfan anemia with very late and fatal onset aplasia in a 55-year-old patient with RPL11 mutation. | Ann Hematol | 2024 | 37993587 | PubTator, text mining | PubMed |
| Perspectives of current understanding and therapeutics of Diamond-Blackfan anemia. | Leukemia | 2024 | 37973818 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6135/papers?page=4